News

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that the heatwave could impact the efficacy of some ...
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
Certain medications, such as antibiotics, diuretics, antidepressants, and treatments for skin issues like acne or eczema, may ...
People taking common medications, including for blood pressure, asthma and diabetes, have been warned to ensure they are ...
The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...
Essential advice on protecting your medicines during extreme heat and staying safe this summer. With the UK bracing for ...
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...
Women in the UK will soon have access to a new daily pill designed to alleviate hot flushes during menopause, following its ...
Medications taken by millions of people carry a risk of sun sensitivity and "severe sunburn", the UK's drug watchdog has ...
Approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the injectable will cut down on immunotherapy ...
Biocon Biologics Ltd received UK approval for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is approved for ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.